Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
Abstract Hyperactivation of ABC transporter ABCB1 and induction of epithelial–mesenchymal transition (EMT) are the most common mechanism of acquired cancer chemoresistance. This study describes possible mechanisms, that might contribute to upregulation of ABCB1 and synergistically boost the acquisit...
Guardado en:
Autores principales: | Raimonda Kubiliute, Indre Januskeviciene, Ruta Urbanaviciute, Kristina Daniunaite, Monika Drobniene, Valerijus Ostapenko, Rimantas Daugelavicius, Sonata Jarmalaite |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0cfe9885eb14543aa4eed855fbd4b5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum protein triplet TGF-β1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma
por: Rūta Urbanavičiūtė, et al.
Publicado: (2021) -
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
por: Mugosa Snezana, et al.
Publicado: (2021) -
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
por: Wang Yin, et al.
Publicado: (2021) -
The MDR1/ABCB1 gene rs1045642 polymorphism in colorectal cancer
por: Beata Mrozikiewicz-Rakowska, et al.
Publicado: (2019) -
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
por: Durgagauri H. Sabnis, et al.
Publicado: (2019)